Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2025-04-28 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
信永中和会计师事务所关于云南生物谷药业股份有限公司2024年度财务报表出具非标审计报告的专项说明
Regulatory Filings
2025-04-28 Chinese
信永中和会计师事务所关于云南生物谷药业股份有限公司2024年度非经营性资金占用及其他关联资金往来的专项说明
Regulatory Filings
2025-04-28 Chinese
2024年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as an "年度报告摘要 2024" which translates to "Annual Report Summary 2024". It contains detailed financial data for the year 2024, including assets, liabilities, net profit, earnings per share, and shareholder information. It also discusses company operations, shareholder changes, and legal matters related to shareholder disputes and judicial auctions. The document is over 11,000 characters, indicating it is a substantive report rather than a brief announcement. The presence of comprehensive financial data and business overview aligns with the characteristics of an Annual Report (10-K equivalent). Therefore, the document is classified as an Annual Report (10-K). FY 2024
2025-04-28 Chinese
关于会计师事务所2024年度履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (audit firm) for the year 2024. It details the qualifications, personnel, business information, quality management, and audit work of the accounting firm for the company's 2024 audit. It does not contain actual financial statements or financial results but rather an assessment of the audit firm's performance and compliance with professional standards. The document length is 3281 characters, which is relatively short and more consistent with an announcement or report on audit performance rather than a full audit report or annual report. This type of document fits the category of Audit Report / Information (AR), which includes standalone audit reports and evaluations related to audit firms and their work, excluding full annual reports. Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-04-28 Chinese
内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制评价报告' which translates to 'Internal Control Evaluation Report'. It is issued by the company's board and discusses the evaluation of the effectiveness of internal controls as of December 31, 2024. The content includes detailed descriptions of internal control principles, scope, execution, risk assessment, and defect identification standards. It is a comprehensive report on internal control evaluation rather than a brief announcement or certification. The document length is 9556 characters, indicating a substantive report. This type of document fits the category of an Audit Report / Information (AR), as it relates to internal control evaluation and audit-related information, but is not a full Annual Report (10-K) or Interim Report (IR). Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-04-28 Chinese
2024年度独立董事述职报告（张倩芸 已离任）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report" for the year 2024 by Zhang Qianyun, who has left the position. It details the independent director's duties, attendance at board and committee meetings, exercise of special powers, communication with auditors, supervision of company governance and information disclosure, training, and other work during the reporting period. The document is a detailed report on the independent director's activities and responsibilities during the year, not an announcement or a brief summary. It does not contain financial statements or audit opinions as a standalone audit report would, nor is it a general regulatory filing or a proxy statement. It is a specialized report related to board/management information, specifically focusing on the independent director's role and activities. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3677 characters, which is sufficient for a detailed report but not a full annual report or interim report. No indication of earnings release, capital update, or other categories is present.
2025-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.